Magnetic resonance spectroscopy in intracranial tumours of glial origin

Alger, 2000, Structural and functional imaging of cerebral neoplasia, 387 Bruhn, 1989, Noninvasive differentiation of tumors with use of localized H1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors, Radiology, 172, 541, 10.1148/radiology.172.2.2748837 Fortuniak, 2010, Magnetic resonance imaging of rare intracranial neoplasms – role of the in vivo 1 H spectroscopy in the radiological differential diagnostics, Cent Eur Neurosurg, 71, 181, 10.1055/s-0030-1261947 Horsztyński, 2003, A study of lyophylized human brain tumor tissue using MAS 1H-MRS spectroscopy, Neurol Neurochir Pol, 37, 123 Kubas, 2001, Magnetic resonance proton spectroscopy in neurooncology – preliminary report, Neurol Neurochir Pol, 35, 90 Negendak, 1996, Proton magnetic resonance spectroscopy in patients with glial tumors. A multicenter study, J Neurosurg, 84, 449, 10.3171/jns.1996.84.3.0449 De Edelenyi, 2000, A new approach for analyzing proton magnetic resonance spectroscopic images of brain tumors: nosologic images, Nat Med, 6, 1287, 10.1038/81401 Bendini, 2011, Primary and metastatic intraaxial brain tumors: prospective comparison of multivoxel 2D chemical-shift imaging (CSI) proton MR spectroscopy, perfusion MRI, and histopathological findings in a group of 159 patients, Acta Neurochir (Wien), 153, 403, 10.1007/s00701-010-0833-0 Fountas, 2004, Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy, Stereotact Funct Neurosurg, 82, 90, 10.1159/000077458 Herminghaus, 2002, Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors, NMR Biomed, 15, 385, 10.1002/nbm.793 Meyerand, 1999, Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy, AJNR Am J Neuroradiol, 20, 117 Chawla, 2010, Proton magnetic resonance spectroscopy in differentiating glioblastomas from primary cerebral lymphomas and brain metastases, J Comput Assist Tomogr, 34, 836, 10.1097/RCT.0b013e3181ec554e Harting, 2003, Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy, Neurosci Lett, 342, 163, 10.1016/S0304-3940(03)00272-6 Ishimaru, 2001, Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy, Eur Radiol, 11, 1784, 10.1007/s003300000814 Chang, 1998, In vivo single-voxel proton MR spectroscopy in intracranial cystic masses, AJNR Am J Neuroradiol, 19, 401 Poptani, 1995, Characterization of intracranial mass lesions with in vivo proton MR spectroscopy, AJNR Am J Neuroradiol, 16, 1593 Möller-Hartmann, 2002, Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions, Neuroradiology, 44, 371, 10.1007/s00234-001-0760-0 Tarnawski, 2002, 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas, Int J Radiat Oncol Biol Phys, 52, 1271, 10.1016/S0360-3016(01)02769-9 Czernicki, 2009, Spectral changes in postoperative MRS in high-grade gliomas and their effect on patient prognosis, Folia Neuropathol, 47, 43 Celda, 2006, MRS as endogenous molecular imaging for brain and prostate tumours: FP6 project “eTUMOUR”, Adv Exp Med Biol, 587, 285, 10.1007/978-1-4020-5133-3_22 Vanhamme, 1997, Improved method for accurate and efficient quantification of MRS data with use of prior knowledge, J Magn Reson, 129, 35, 10.1006/jmre.1997.1244 Fan, 2004, In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases, Clin Radiol, 59, 77, 10.1016/j.crad.2003.08.006 Gajewicz, 2003, The use of proton MRS in the differential diagnosis of brain tumors and tumor-like processes, Med Sci Monit, 9, 97 Kleinhues, 2000 Florian, 1995, Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours, NMR Biomed, 8, 253, 10.1002/nbm.1940080605 Kinoshita, 1997, Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy, NMR Biomed, 10, 2, 10.1002/(SICI)1099-1492(199701)10:1<2::AID-NBM442>3.0.CO;2-N Nadler, 1972, N-acetyl-L-aspartic acid content of human neural tumors and bovine peripheral nervous tissues, J Neurochem, 19, 313, 10.1111/j.1471-4159.1972.tb01341.x Wilken, 2000, Quantitative proton magnetic resonance spectroscopy of focal brain lesions, Pediatr Neurol, 23, 22, 10.1016/S0887-8994(00)00141-7 Lowry, 1977, Diversity of metabolic patterns in human brain tumors. High energy phosphate compounds and basic composition, J Neurochem, 29, 959, 10.1111/j.1471-4159.1977.tb06500.x Kondziolka, 1993, Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low grade) astrocytoma, J Neurosurg, 79, 533, 10.3171/jns.1993.79.4.0533 Podo, 1999, Tumor phospholipid metabolism, NMR Biomed, 12, 413, 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U Ruiz-Cabello, 1992, Phospholipid metabolites as indicators of cancer cell function, NMR Biomed, 5, 226, 10.1002/nbm.1940050506 Gotsis, 1996, In vivo proton MR spectroscopy: the diagnostic possibilities of lipid resonances in brain tumors, Anticancer Res, 16, 1565 Herholz, 1992, In vivo imaging of glucose consumption and lactate concentration in human gliomas, Ann Neurol, 31, 319, 10.1002/ana.410310315 Arnold, 1990, Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. Preliminary observations on tumor grading, NMR Biomed, 3, 184, 10.1002/nbm.1940030407 Fulham, 1992, Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance, Radiology, 185, 675, 10.1148/radiology.185.3.1438744 Heesters, 1993, Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy, J Neurooncol, 17, 27, 10.1007/BF01054271 Henriksen, 1991, In vivo 1H-spectroscopy of human intracranial tumors at 1,5 Tesla. Preliminary experience at a clinical installation, Acta Radiol, 32, 95, 10.3109/02841859109177522 Kugel, 1992, Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy, Radiology, 183, 701, 10.1148/radiology.183.3.1584924 Liu, 2012, Noninvasive evaluation of cerebral glioma grade by using diffusion-weighted imagingguided single-voxel proton magnetic resonance spectroscopy, J Int Med Res, 40, 76, 10.1177/147323001204000108 Ott, 1993, Human brain tumours: assessment with in vivo proton MR spectroscopy, Radiology, 186, 745, 10.1148/radiology.186.3.8430183 Segebarth, 1990, Detection of metabolic heterogenity of human intracranial tumors in vivo by 1H NMR spectroscopic imaging, Magn Reson Med, 13, 62, 10.1002/mrm.1910130108 Sutton, 1992, Proton magnetic resonance spectroscopy of pediatric brain tumors, Neurosurgery, 31, 195, 10.1227/00006123-199208000-00004 Usenius, 1994, Quantitative metabolite patterns of human brain tumors: detection by 1H NMR spectroscopy in vivo and in vitro, J Comput Assist Tomogr, 18, 705, 10.1097/00004728-199409000-00005 Demaerel, 1991, Localized HNMR spectroscopy in fifty cases of newly diagnosed intracranial tumors, J Comput Assist Tomogr, 15, 67, 10.1097/00004728-199101000-00009 Gill, 1990, Proton spectroscopy of intracranial tumours: in vivo and in vitro studies, J Comput Assist Tomogr, 14, 497, 10.1097/00004728-199007000-00001 Peeling, 1992, 1H NMR spectroscopy studies of extracts of human cerebral neoplasms, Magn Reson Med, 24, 123, 10.1002/mrm.1910240113 Hagberg, 1995, In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi dimensional classification, Magn Reson Med, 34, 242, 10.1002/mrm.1910340216 Herminghaus, 2003, Determination of histopathological tumor grade in neuroepithelial brain tumors by using spectral pattern analysis of in vivo spectroscopic data, J Neurosurg, 98, 74, 10.3171/jns.2003.98.1.0074 Maxwell, 1998, Pattern recognition analysis of H1 NMR spectra from perchloric acid extracts of human brain tumor biopsies, Magn Reson Med, 39, 869, 10.1002/mrm.1910390604 Castillo, 2000, Correlation of myo-inositol levels and grading of cerebral astrocytomas, AJNR Am J Neuroradiol, 21, 1645 Franke, 1997, Direct regulation of the AKT protooncogene product by phosphatidylinositol 3,4+bisphosphate, Science, 275, 665, 10.1126/science.275.5300.665 Toker, 1997, Signalling through the lipid products of phosphoinisitide-3-OH kinase, Nature, 387, 673, 10.1038/42648 Uhm, 1996, Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C, Clin Exp Metastasis, 14, 421, 10.1007/BF00128958 Candiota, 2011, Non-invasive grading of astrocytic tumours from the relative contents of myoinositol and glycine measured by in vivo MRS, JBR-BTR, 94, 319 Cheng, 1998, Correlation of high resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens, J Cancer Res, 58, 1825 Bobek-Billewicz, 2010, Measurement of glycine in a brain and brain tumors by means of 1H MRS, Folia Neuropathol, 48, 190 Rijpkema, 2003, Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging, NMR Biomed, 16, 12, 10.1002/nbm.807 Tugnoli, 1998, Magnetic resonance spectroscopy study of low grade extra and intracerebral human neoplasms, Oncol Rep, 5, 1199